Gemcitabine, dexamethasone and cisplatin with or without rituximab is highly effective as a mobilization regimen in relapsed or refractory lymphoma. [PDF]
Taillefer VT +4 more
europepmc +1 more source
Daratumumab combined with anti-CD20 therapy in pediatric and adult refractory idiopathic nephrotic syndrome: single-center experience. [PDF]
Naciri Bennani H +8 more
europepmc +1 more source
The High Price of Interrupted Follow-Up: Catastrophic Progression of Homozygous Familial Hypercholesterolemia-A Case Report and Literature Review. [PDF]
Dastjerdi P +5 more
europepmc +1 more source
Evaluation of peripheral blood stem cell collection in the Japan Marrow Donor Program (JMDP). [PDF]
Yamazaki R +16 more
europepmc +1 more source
Associations between CT Radiomics Analyses and Hematopoietic Cell Mobilization in Patients with Multiple Myeloma: An Exploratory Analysis. [PDF]
Leonhardi J +13 more
europepmc +1 more source
Latent iron deficiency as a silent driver of donor attrition in high-frequency plateletpheresis donors: a longitudinal cohort study. [PDF]
Jin L +6 more
europepmc +1 more source
Evolving TRALI risk across apheresis and whole blood platelet products in the United States: An 18-year American Red Cross hemovigilance analysis. [PDF]
Young PP, Singh U, Webb J, Looney MR.
europepmc +1 more source
Baseline characteristics and response to evinacumab in females and males with homozygous familial hypercholesterolemia in the ELIPSE OLE study. [PDF]
Brisson D +5 more
europepmc +1 more source
The French Experience of Pharmacists and CAR T-Cells: A Study of the French Society of Oncology Pharmacy (SFPO). [PDF]
Schwiertz V +19 more
europepmc +1 more source

